Herpes simplex virus decreases endothelial cell plasminogen activator inhibitor

R. A. Bok, H. S. Jacob, J. Balla, M. Juckett, T. Stella, M. A. Shatos, G. M. Vercellotti

Research output: Contribution to journalArticlepeer-review

16 Scopus citations


Herpes simplex virus (HSV) infection is histopathologically associated with vascular injury, fibrinoid necrosis and inflammatory cell infiltrates. We have previously shown in vitro that HSV infection of human umbilical vein endothelial cells (HUVEC) promotes a procoagulant phenotype manifest by the induction of tissue factor, the loss of thrombomodulin, and an increase in platelet adhesion. In these studies we examined the effects of HSV infection on HUVEC plasminogen activator inhibitor type 1 (PAI-1) and tissue plasminogen activator (t-PA). HSV infection caused the loss of PAI-1 in the extracellular matrix (ECM) and that released into the supernatant of HUVEC. Both activity and antigen levels of the Serpin inhibitor are diminished as a result of HSV infection. The loss of inhibitor is not secondary to diminished vitronectin (Vn), the primary binding protein of PAI-1 in the ECM, but appears to be secondary to decreased synthesis at the RNA level. Tissue plasminogen activator (t-PA) synthesis is also decreased in endothelial HSV infection. PAI-1 loss may further promote a procoagulant phenotype in HSV infection in vivo.

Original languageEnglish (US)
Pages (from-to)253-258
Number of pages6
JournalThrombosis and Haemostasis
Issue number3
StatePublished - 1993


Dive into the research topics of 'Herpes simplex virus decreases endothelial cell plasminogen activator inhibitor'. Together they form a unique fingerprint.

Cite this